U.S. Markets closed

Rosetta Genomics Ltd. (ROSG)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.66+0.05 (+3.11%)
At close: 3:59PM EDT
People also watch
RXIIPSTICLSNCYCCOPXA
  • J
    Justin
    Justin
    Kenny diluting more next month and no word of any earnings... what a #$%$ bag!
  • T
    Tyler
    Tyler

    Found a great no fee daytrading newsletter, vist www.T0pm@rketgainers.c0m and sign up...so glad I did.

  • n
    nick
    nick
    Any Palestinians invest in this? You're closer than we are.. if u know what I mean.. I didn't lose much on this but I'm sorry for those that did. 400K a year goes to the CEO with probably the worst performing stock ever in the Nasdaq? What a Jew scam artists.
  • G
    Gannon
    Gannon
    Largest Galners 0n the NASDAQ & NYSE ---> T0pMarketGalners.c0m
  • J
    Jake
    Jake
    Do you understand that no one buys their tests? There are so many other better run companies that sell these type of tests. I told you long ago that this company will shut its doors. It is a joke. Last cash grab before out of business. You should not buy this trash.
  • J
    Jake
    Jake
    Been saying this for a long time, Kenny is a con artist and he is scamming people!
  • M
    Mark
    Mark
    Shares have to be above $1.50 for these investors to sell, right?
  • L
    Littleguy
    Littleguy
    Once again, current shareholders are screwed. Berlin said not long ago that they would look to add capital through some other way than by issuing more shares. Price rose to $2.60. Now they price a secondary at 1.50 with warrants to buy at 1.40. So, the new share holders sell all of their shares at any price above 1.50 and hold onto the warrants in case price actually does go up. They have no cash investment (i.e. no downside risk) and the chance to make some money if ROSG finds a cure for stupid management.
  • L
    Littleguy
    Littleguy
    Earnings are going to be released in the next couple of weeks. Bet ya that losses are at least half of the cash generated by this secondary. I doubt that revenue will be even half of the amount of the secondary offering.
  • L
    Littleguy
    Littleguy
    At the current market price, Berlin would have to increase the number of shares by 50% just to get the market cap back to where it was a week ago. This is like adding water to a thin soup: you have more to serve, but there's not much taste or nutrition in every spoonful.
  • m
    michael
    michael
    deal done under 1 dollar. raise 3m bucks...dilution 80percent of the company...insane...worst mgmt and board in history...all should be barred from working for public companies
  • b
    blue
    blue
    gedy for ascary scary crash crashbelow 1.50 be veryvery af money run run to the exit exit door get ouout beterbesafe than sorry
  • m
    michael
    michael
    only abke to raise 3m bucks. so sad. sub 1 next 30 days
  • L
    Littleguy
    Littleguy
    When, if ever, has a management action resulted in a higher stock price? It seems to me that any rise in share price is an invitation by management to bring it back down.
  • n
    nick
    nick
    Has anyone tried actually suing this company before, just curious? I'm in on small shares but jeez I have never, ever seen this thing going up. Where are the lawsuits?
  • J
    Jake
    Jake
    When the pumpers came in last couple of weeks, I knew that this was going to take a chtz! Shorts love this stock! Ken Berlin will be looking over his shoulder for the rest of his life, FBI, etc; all for greed!
  • L
    Littleguy
    Littleguy
    10% of market cap. Last I read, Ken's annual salary is $500K. That's over 10% of market cap. Imagine if any other CEO were paid that much. #$%$ company with stinking leadership.
  • m
    michael
    michael
    60 oercent dilution for 2 months of burn...sad
  • n
    nick
    nick
    I understand the CEO is in Israel trying to avoid SEC charges and lawsuits against him and his cronies. There's got to be some way to get the guy since it's listed on the NASDAQ.. America can still go after foreign nationals, I am assuming he is American or is he Isreali?
  • J
    Justin
    Justin
    Kenny lie on May 21st:

    "Since announcing our strategic focus on RosettaGX Reveal™ (Reveal) and the exploration of alternatives for our PersonalizeDx business at the start of this month, we have received inquiries from multiple parties expressing interest in acquiring our PersonalizeDx business," said Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics. "In parallel, the current market conditions for selling equity are not favorable to microcap companies, and we believe the terms proposed to us by potential investors are not in the best interest of our shareholders. As such, we are suspending plans to raise capital under the Form F-1 registration statement until further notice, and instead will continue to explore other means to improve our cash position. The potential sale of our PersonalizeDx business would have the benefit of bringing in non-dilutive cash as well as reducing our cash burn rate by approximately 20%. We also are pursuing opportunities to monetize certain IP assets, which represent another potential source of non-dilutive cash, and are exploring several other avenues for raising capital."